Paula J. Olsiewski, PhD: “Healthcare workers at hospitals are always concerned about the air because historically, we know many disease agents are transmitted through the air, whether it’s measles or tuberculosis. Those appear on the scene long before COVID-19.”
Believe it or not, it could have been worse, Paula J. Olsiewski, PhD, a contributing scholar at the Johns Hopkins Center for Health Security tells Infection Control Today®. Olsiewski has held many positions at many institutions including the Environmental Protection Agency, the Department of Homeland Security and the Alfred P. Sloan Foundation where she procured 230 grants totaling $150 million to support research by indoor air scientists and engineers. Olsiewski points out that hospitals follow ventilation guidelines set forth by the American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE). “Hospitals have been well prepared for, say tuberculosis,” Olsiewski tells ICT®. “And that’s not a nice disease to get. We’ve had recent measles outbreaks, because of people’s reluctance to give their children the vaccine. Again, that has been a challenge to our healthcare system. But the hospitals generally are well designed.”
Olsiewski argues that one of the problems with fighting coronavirus disease 2019 (COVID-19), especially at the beginning, is that “medical doctors who are doing a fabulous job, during this pandemic, are not experts in fluid dynamics, they are not up to date on the most recent literature for how viruses flow…. This pandemic started last December, but the World Health Organization did not recognize aerosol transmission until sometime in the summer. The US Centers for Disease Control and Prevention did not recognize the airborne transmission until October.”
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
Infection Intel: Revolutionizing Ultrasound Probe Disinfection With Germitec's Chronos
November 19th 2024Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies